Page last updated: 2024-08-23

buserelin and epidermal growth factor

buserelin has been researched along with epidermal growth factor in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's4 (57.14)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bakker, GH; de Jong, FH; Foekens, JA; Klijn, JG; Meijers, M; van Garderen-Hoetmer, A; Woutersen, RA1
Miller, WR; Mullen, P; Scott, WN1
Costantini, A; De Bellis, A; Fiorelli, G; Longo, A; Natali, A; Serio, M1
Baird, DT; Bramley, T; Lumsden, MA; Rumgay, L; West, CP1
Matsumi, H; Morita, Y; Schally, AV; Taketani, Y; Tsutsumi, O; Yano, N; Yano, T1
Conn, PM; Han, XB1
Esumi, H; Koji, T; Kugu, K; Kurashima, Y; Matsumi, H; Ogura, T; Osuga, Y; Taketani, Y; Tang, X; Tsutsumi, O; Xu, JP; Yano, N; Yano, T1

Other Studies

7 other study(ies) available for buserelin and epidermal growth factor

ArticleYear
Effects of castration, alone and in combination with aminoglutethimide, on growth of (pre)neoplastic lesions in exocrine pancreas of rats and hamsters.
    Carcinogenesis, 1991, Volume: 12, Issue:9

    Topics: Aminoglutethimide; Animals; Azaserine; Body Weight; Buserelin; Carcinogens; Cricetinae; Epidermal Growth Factor; Gastrins; Goserelin; Male; Mesocricetus; Nitrosamines; Orchiectomy; Organ Size; Pancreatic Neoplasms; Precancerous Conditions; Rats; Rats, Inbred Strains; Somatomedins; Testosterone

1991
Factors influencing the response of MCF-7 cells to an agonist of luteinising hormone-releasing hormone.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:11

    Topics: Breast Neoplasms; Buserelin; Cell Line; Culture Media; Epidermal Growth Factor; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Insulin; Tumor Cells, Cultured

1991
Epidermal growth factor receptors in human hyperplastic prostate tissue and their modulation by chronic treatment with a gonadotropin-releasing hormone analog.
    The Journal of clinical endocrinology and metabolism, 1989, Volume: 68, Issue:4

    Topics: Aged; Binding Sites; Buserelin; Dihydrotestosterone; Epidermal Growth Factor; ErbB Receptors; Goserelin; Humans; Male; Middle Aged; Models, Biological; Prostatic Hyperplasia; Testosterone

1989
The binding of epidermal growth factor to the human uterus and leiomyomata in women rendered hypo-oestrogenic by continuous administration of an LHRH agonist.
    British journal of obstetrics and gynaecology, 1988, Volume: 95, Issue:12

    Topics: Adult; Buserelin; Epidermal Growth Factor; Estradiol; Female; Goserelin; Humans; Leiomyoma; Menstrual Cycle; Myometrium; Uterine Neoplasms

1988
Effect of luteinizing hormone-releasing hormone analogs on the rat ovarian follicle development.
    Hormone research, 1997, Volume: 48 Suppl 3

    Topics: Animals; Apoptosis; Buserelin; Cells, Cultured; Epidermal Growth Factor; Female; Gonadotropin-Releasing Hormone; Granulosa Cells; Organ Culture Techniques; Ovarian Follicle; Protein-Tyrosine Kinases; Rats; Rats, Wistar

1997
The role of protein kinases A and C pathways in the regulation of mitogen-activated protein kinase activation in response to gonadotropin-releasing hormone receptor activation.
    Endocrinology, 1999, Volume: 140, Issue:5

    Topics: Animals; Bucladesine; Buserelin; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Indoles; Kinetics; Maleimides; Protein Kinase C; Rats; Receptors, LHRH; Signal Transduction; Tetradecanoylphorbol Acetate; Transfection

1999
Regulation of nitric oxide synthase to promote cytostasis in ovarian follicular development.
    Biology of reproduction, 2000, Volume: 63, Issue:1

    Topics: Animals; Apoptosis; Buserelin; Cell Division; Cells, Cultured; Epidermal Growth Factor; Female; Gonadotropin-Releasing Hormone; Granulosa Cells; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Ovarian Follicle; Ovary; Penicillamine; Rats; Rats, Wistar; Thymidine

2000